534 related articles for article (PubMed ID: 31733111)
21. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
[TBL] [Abstract][Full Text] [Related]
22. Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands.
Kang KY; Kim HO; Kwok SK; Ju JH; Park KS; Sun DI; Jhun JY; Oh HJ; Park SH; Kim HY
Arthritis Res Ther; 2011; 13(5):R179. PubMed ID: 22030011
[TBL] [Abstract][Full Text] [Related]
23. Epigenetically quantified immune cells in salivary glands of Sjögren's syndrome patients: a novel tool that detects robust correlations of T follicular helper cells with immunopathology.
Blokland SLM; van Vliet-Moret FM; Hillen MR; Pandit A; Goldschmeding R; Kruize AA; Bouma G; van Maurik A; Olek S; Hoffmueller U; van Roon JAG; Radstake TRDJ
Rheumatology (Oxford); 2020 Feb; 59(2):335-343. PubMed ID: 31325310
[TBL] [Abstract][Full Text] [Related]
24. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
[TBL] [Abstract][Full Text] [Related]
25. Salivary chemokine levels in patients with primary Sjogren's syndrome.
Lee YJ; Scofield RH; Hyon JY; Yun PY; Lee HJ; Lee EY; Lee EB; Song YW
Rheumatology (Oxford); 2010 Sep; 49(9):1747-52. PubMed ID: 20525739
[TBL] [Abstract][Full Text] [Related]
26. CXCL9, 10, 11/CXCR3 Axis Contributes to the Progress of Primary Sjogren's Syndrome by Activating GRK2 to Promote T Lymphocyte Migration.
Zhang J; Zhang X; Shi X; Liu Y; Cheng D; Tian Q; Lin N; Wei W; Wu H
Inflammation; 2023 Jun; 46(3):1047-1060. PubMed ID: 36801996
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren's syndrome is associated with increased disease activity.
Hillen MR; Kruize AA; Bikker A; Wenting-van Wijk M; Radstake TR; Hack CE; Lafeber FP; van Roon JA
Mod Rheumatol; 2016; 26(1):105-9. PubMed ID: 25995032
[TBL] [Abstract][Full Text] [Related]
28. Expression of the interferon-gamma-inducible 10-kd protein and CXC receptor 3 in the salivary gland lesions of patients with Sjögren's syndrome: comment on the article by Ogawa et al.
Sfriso P; Calabrese F; Grava C; Agostini C; Punzi L; Oliviero F; Botsios C; Ostuni PA; Todesco S
Arthritis Rheum; 2003 Aug; 48(8):2390-1; author reply 2391-2. PubMed ID: 12905497
[No Abstract] [Full Text] [Related]
29. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
Cornec D; Costa S; Devauchelle-Pensec V; Jousse-Joulin S; Marcorelles P; Berthelot JM; Chiche L; Hachulla E; Hatron PY; Goeb V; Vittecoq O; Saraux A; Pers JO
J Autoimmun; 2016 Feb; 67():102-110. PubMed ID: 26688003
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
Hansen A; Reiter K; Ziprian T; Jacobi A; Hoffmann A; Gosemann M; Scholze J; Lipsky PE; Dörner T
Arthritis Rheum; 2005 Jul; 52(7):2109-19. PubMed ID: 15986367
[TBL] [Abstract][Full Text] [Related]
31. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
[TBL] [Abstract][Full Text] [Related]
32. Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.
Li N; Li L; Wu M; Li Y; Yang J; Wu Y; Xu H; Luo D; Gao Y; Fei X; Jiang L
Front Immunol; 2021; 12():697157. PubMed ID: 34367157
[TBL] [Abstract][Full Text] [Related]
33. Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
Blokland SLM; Hillen MR; Wichers CGK; Zimmermann M; Kruize AA; Radstake TRDJ; Broen JCA; van Roon JAG
RMD Open; 2019; 5(1):e000701. PubMed ID: 30713717
[No Abstract] [Full Text] [Related]
34. IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren's Syndrome Patients.
Luo J; Ming B; Zhang C; Deng X; Li P; Wei Z; Xia Y; Jiang K; Ye H; Ma W; Liu Z; Li H; Yang XP; Dong L
Front Immunol; 2018; 9():1755. PubMed ID: 30150979
[TBL] [Abstract][Full Text] [Related]
35. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
[TBL] [Abstract][Full Text] [Related]
36. NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.
Pontarini E; Sciacca E; Grigoriadou S; Rivellese F; Lucchesi D; Fossati-Jimack L; Coleby R; Chowdhury F; Calcaterra F; Tappuni A; Lewis MJ; Fabris M; Quartuccio L; Bella SD; Bowman S; Pitzalis C; Mavilio D; De Vita S; Bombardieri M
Front Immunol; 2021; 12():706737. PubMed ID: 34594326
[TBL] [Abstract][Full Text] [Related]
37. CCL5 Release by CCR9+ CD8 T Cells: A Potential Contributor to Immunopathology of Primary Sjögren's Syndrome.
Hinrichs AC; Blokland SLM; Kruize AA; Lafeber FPJ; Leavis HL; van Roon JAG
Front Immunol; 2022; 13():887972. PubMed ID: 35720379
[TBL] [Abstract][Full Text] [Related]
38. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
39. A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity.
McGuire HM; Vogelzang A; Ma CS; Hughes WE; Silveira PA; Tangye SG; Christ D; Fulcher D; Falcone M; King C
Immunity; 2011 Apr; 34(4):602-15. PubMed ID: 21511186
[TBL] [Abstract][Full Text] [Related]
40. B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.
Verstappen GM; Kroese FG; Meiners PM; Corneth OB; Huitema MG; Haacke EA; van der Vegt B; Arends S; Vissink A; Bootsma H; Abdulahad WH
J Rheumatol; 2017 Jan; 44(1):49-58. PubMed ID: 28042126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
